Skip to search formSkip to main contentSkip to account menu

indenolol

Known as: 1-(1H-inden-7-yloxy)-3-((1-methylethyl)amino)-2-propanol, hydrochloride, 1-(7-indenyloxy)-3-isopropylaminopropan-2-ol.HCl 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1989
1989
The effects of indenolol and nadolol and of their respective fluorinated derivatives on ventricular fibrillation threshold were… 
1989
1989
Intrinsic sympathomimetic activity may attenuate some effects caused by treatment with β‐adrenoceptor blockers. Indenolol is a… 
1987
1987
The antihypertensive effects of indenolol, a new not‐cardioselective β‐blocking agent, were evaluated in patients with WHO grades… 
1987
1987
In 20 patients with mild or moderate essential hypertension who responded favorably to indenolol antihypertensive therapy… 
1985
1985
The antihypertensive efficacy of a new agent, indenolol, was compared with that of the well‐established antihypertensive drug… 
1985
1985
Thirty-four hyperthyroid patients were divided into four groups: placebo, carteolol (20 mg/day), indenolol (60 mg/day) and… 
1983
1983
After a complete washout 14 hypertensive inpatients were given placebo for 3 days. Undistinguishable 30‐ or 60‐mg indenolol… 
1981
1981
Two studies were conducted on indenolol, a new β‐adrenoceptor blocker. In the first, nine healthy men received indenolol 40, 80…